Latest News and Press Releases

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Wilmington, Delaware, Transparency Market Research Inc. –, March 05, 2025 (GLOBE NEWSWIRE) -- The Canine Atopic Dermatitis Market (Marché de la dermatite atopique canine) is expected to expand...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The "Janus Kinase (JAK)...

Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region,...

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution...

New York, USA, May 15, 2024 (GLOBE NEWSWIRE) -- JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies -  Eli Lilly and Company, Incyte Corporation, Dompé...

Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...

EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...

Exton, Pennsylvania, Nov. 30, 2023 (GLOBE NEWSWIRE) -- With the Ulcerative Colitis (UC) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment,...